Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma
Ponsky L, Lo SS, Zhang Y, Schluchter M, Liu Y, Patel R, Abouassaly R, Welford S, Gulani V, Haaga JR, Machtay M, Ellis RJ | Radiother Oncol | 2015
Stereotactic Body Radiotherapy for Large Primary Renal Cell Carcinoma
S Kaidar-Person O, Price A, Schreiber E, Zagar TM, Chen RC | Clin Genitourin Cancer | 2017
Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function
Senger C, Conti A, Kluge A, Pasemann D, Kufeld M, Acker G, Lukas M, Grün A, Kalinauskaite G, Budach V, Waiser J, Stromberger C | BMC Urol | 2019
Propensity Score-Matched Analysis of Single Fraction Robotic Radiosurgery Versus Open Partial Nephrectomy in Renal Cell Carcinoma: Oncological Outcomes
Michael Staehler, Tina Schuler, Annabel Spek, Severin Rodler, Alexander Tamalunas, Christoph Fürweger, Alexander Muacevic | Cureus | 2022
Robotic stereotactic body radiotherapy for the management of adrenal gland metastases: a bi-institutional analysis
Felix Ehret, David Kaul, Markus Kufeld, Clara Vom Endt, Volker Budach, Carolin Senger , Christoph Fürweger , Alfred Haidenberger , Alexander Muacevic | J Cancer Res Clin Oncol | 2022
Stereotactic Body Radiotherapy (SBRT) Reirradiation for Recurrent Pancreas Cancer
Dagoglu N, Callery M, Moser J, Tseng J, Kent T, Bullock A, Miksad R, Mancias JD, Mahadevan A | J Cancer | 2016
Five-Fraction Stereotactic Body Radiation Therapy (SBRT) and Chemotherapy for the Local Management of Metastatic Pancreatic Cancer
Lischalk JW, Burke A, Chew J, Elledge C, Gurka M, Marshall J, Pishvaian M, Collins S, Unger K. | J Gastrointest Cancer | 2018
Clinical outcomes and prognostic factors of stereotactic body radiation therapy combined with gemcitabine plus capecitabine for locally advanced unresectable pancreatic cancer
Shen ZT, Zhou H, Li AM, Ji XQ, Jiang CC, Yuan X, Li B, Zhu XX, Huang GC | J Cancer Res Clin Oncol | 2020
Gated Volumetric-Modulated Arc Therapy vs. Tumor-Tracking CyberKnife Radiotherapy as Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Dosimetric Comparison Study Focused on the Impact of Respiratory Motion Managements
Yoon K, Kwak J, Cho B, Park JH, Yoon SM, Lee SW, Kim JH | PLoS One | 2016
Long-term Survival in Patients Treated with a Robotic Radiosurgical Device for Liver Metastases
Stintzing S, Einem JV, Fueweger C, Haidenberger A, Fedorov M, Muavcevic A | Cancer Res Treat | 2019
Single community-based institutional series of stereotactic body radiation therapy (SBRT) for treatment of liver metastases
Anstadt EJ, Shumway R, Colasanto J, Grew D | J Gastrointest Oncol | 2019
Challenges of BCLC stage C hepatocellular carcinoma: Results of a single-institutional experience on stereotactic body radiation therapy
Que J, Lin CH, Lin LC, Ho CH | Medicine (Baltimore) | 2020
Cyberknife Radiosurgery in Hepatocellular Carcinoma
Memon B, Kadri S, Sultana N, Saeed K, Ahmed N, Mahmood T | J Coll Physicians Surg Pak | 2021
Hepatocellular carcinoma patients with portal vein thrombosis treated with robotic radiosurgery: Interim results of a prospective study
Dutta D, Tatineni T, Yarlagadda S, Gupte A, Reddy SK, Madhavan R, Nair H, Sasidharan A, Kannan R, Pottayil SG, Holla R, Sudhindran S | Indian J Gastroenterol | 2021
Hepatic Resection Versus Stereotactic Body Radiation Therapy Plus Transhepatic Arterial Chemoembolization for Large Hepatocellular Carcinoma: A Propensity Score Analysis
Sun J, Li WG, Wang Q, He WP, Wang HB, Han P, Zhang T, Zhang AM, Fan YZ, Sun YZ, Duan XZ | J Clin Transl Hepatol | 2021
Adjuvant stereotactic body radiotherapy after marginal resection for hepatocellular carcinoma with microvascular invasion: A randomised controlled trial
Shi C, Li Y, Geng L, Shen W, Sui C, Dai B, Lu J, Pan M, Yang J. | Eur J Cancer | 2022
Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
Lischalk JW, Malik RM, Collins SP, Collins BT, Matus IA, Anderson ED | Radiat Oncol. | 2016
Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation
Repka MC, Aghdam N, Kataria SK, Campbell L, Suy S, Collins SP, Anderson E, Lischalk JW, Collins BT | Radiat Oncol. | 2017
Factors affecting local control of pulmonary oligometastases treated with stereotactic body radiotherapy
Sharma A, Duijm M, Oomen-de Hoop E, Aerts JG, Verhoef C, Hoogeman M, Nuyttens JJ. | Acta Oncol | 2018
Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer
Sumodhee S, Bondiau PY, Poudenx M, Cohen C, Naghavi AO, Padovani B, Maneval D, Gal J, Leysalle A, Ghalloussi H, Otto J, Doyen J | BMC Cancer | 2019
